Nurse Practitioner, Adult Health · Amherst, NY
NPI
1619129764
Since 2008
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3980 Sheridan Dr
Amherst, NY, 14226
Phone (716) 250-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
12,017 services
Medicare patients, 2024
70
Average age 63
Drug cost, 2024
$664K
1,750 prescriptions
Company payments, 2025
$12K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle M Gilliland was code J0585 (injection, onabotulinumtoxina, 1 unit), 11,600 times for 22 patients. In total Michelle M Gilliland billed 12,017 services in 13 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 11,600 | 22 | $4.81 | $56K |
| 64450 Musculoskeletal | Office | 77 | 16 | $54.22 | $4,175 |
| 64405 Musculoskeletal | Office | 75 | 16 | $28.51 | $2,139 |
| 20553 Musculoskeletal | Office | 59 | 19 | $30.96 | $1,827 |
| 64615 Musculoskeletal | Office | 58 | 22 | $95.75 | $5,554 |
| 99215 Office E&M - Established | Office | 38 | 30 | $110.60 | $4,203 |
By year: 2022 $66K for 8,970 services; 2023 $63K for 9,230 services; 2024 $76K for 12,017 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle M Gilliland prescribed most often to Medicare patients was Sumatriptan Succinate, with 169 prescriptions and refills. In total Michelle M Gilliland wrote 1,750 Medicare prescriptions that cost $664K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sumatriptan Succinate Generic | 169 | 199 | 37 | $26K |
| Ubrelvy Ubrogepant | 159 | 159 | 34 | $201K |
| Nurtec Odt Rimegepant Sulfate | 127 | 127 | 35 | $135K |
| Rizatriptan Rizatriptan Benzoate | 118 | 130 | 30 | $1,856 |
| Amitriptyline Hcl Generic | 114 | 145 | 20 | $1,205 |
| Gabapentin Generic | 100 | 145 | 22 | $1,125 |
| Qulipta Atogepant | 93 | 94 | 11 | $101K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 81 | 95 | 19 | $66K |
| Topiramate Generic | 81 | 116 | 15 | $703 |
| Aimovig Autoinjector Erenumab-Aooe | 59 | 69 | 12 | $46K |
| Tizanidine Hcl Generic | 54 | 68 | 20 | $408 |
| Ondansetron Hcl Generic | 48 | 48 | 13 | $289 |
| Nortriptyline Hcl Generic | 44 | 55 | Under 11 | $613 |
| Methylprednisolone Generic | 36 | 36 | 33 | $229 |
| Cyclobenzaprine Hcl Generic | 35 | 43 | Under 11 | $255 |
Brand drugs: 619 claims; generic drugs: 1,131 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle M Gilliland $12K ($12K in general payments such as food, travel and fees) from 27 companies. The largest payer was Axsome Therapeutics, Inc. with $8,646.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 16 | $8,646 |
| Abbvie Inc. ABBV | 63 | $996 |
| Tonix Medicines, Inc. | 34 | $256 |
| UCB, Inc. UCB.BR | 5 | $220 |
| Scilex Pharmaceuticals Inc. | 29 | $217 |
| MDD US Operations, LLC | 11 | $192 |
| Teva Pharmaceuticals USA, Inc. TEVA | 11 | $155 |
| SK Life Science, Inc. | 1 | $144 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $125 |
| Abbott Laboratories ABT | 1 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.